| Active substance |
Ketoconazole |
| Also known as |
Nizoral |
| Blood pressure |
No significant impact |
| Chemical name |
(В±)-cis-1-Acetyl-4-[4-[[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazine |
| Dosage (medical) |
200-400 mg daily orally, or 2% topical cream applied once daily |
| Dosage (sports) |
Not applicable |
| Effects |
Antifungal |
| Formula |
C26H28Cl2N4O4 |
| Half-life |
8 hours |
| Hepatotoxicity |
Yes, can cause serious liver damage |
| Lab Test |
Liver function tests |
| Main action |
Inhibits fungal ergosterol synthesis |
| Side effects |
Nausea, vomiting, hepatotoxicity, pruritus, dizziness |
| Storage conditions |
Store at room temperature away from moisture and heat |
| Strength |
2% |
| Substance class |
Antifungal |
| Trade name |
Nizoral, Extina, Xolegel, Ketodan |
| Use in sports |
Not typically used in sports |
| Water Retention |
None |
| Manufacturer |
Hedge & Hedge Pharmaceuticals LLP |
| Packing |
1 tube/pack |
